Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic component of metabolic syndrome. Despite the beneficial health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no previous human study has been conducted on the efficacy of cardamom in NAFLD. The aim o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nutr Metab (Lond)
Autores principales: Daneshi-Maskooni, Milad, Keshavarz, Seyed Ali, Qorbani, Mostafa, Mansouri, Siavash, Alavian, Seyed Moayed, Badri-Fariman, Mahtab, Jazayeri-Tehrani, Seyed Ali, Sotoudeh, Gity
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6156864/
https://ncbi.nlm.nih.gov/pubmed/30263038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-018-0297-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares